660 related articles for article (PubMed ID: 32808104)
41. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
42. Primary gastrointestinal follicular lymphoma with histological transformation.
Hangai S; Nakamura F; Kamikubo Y; Ichikawa M; Suzuki H; Yoshida S; Yamada A; Takazawa Y; Fukayama M; Koike K; Kurokawa M
Ann Hematol; 2013 Jul; 92(7):993-4. PubMed ID: 23271213
[No Abstract] [Full Text] [Related]
43. Simultaneous occurrence of der(1;7)(q10;p10) and t(14;18)(q32;q21) in non-Hodgkin's lymphoma: der(1;7) will appear as a secondary change in lymphoid neoplasia.
Hsiao HH; Sashida G; Ito Y; Tachino M; Beppu H; Ohyashiki K
Leuk Lymphoma; 2005 Jun; 46(6):949-50. PubMed ID: 16019545
[No Abstract] [Full Text] [Related]
44. Malignant histiocytosis with multiple skin lesions in a dog.
Uno Y; Momoi Y; Watari T; Goitsuka R; Tsujimoto H; Shimada T; Ono K; Goto N; Hasegawa A
J Vet Med Sci; 1993 Dec; 55(6):1059-61. PubMed ID: 8117808
[TBL] [Abstract][Full Text] [Related]
45. Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
Paszkiewicz-Kozik E; Kulik J; Fabisiewicz A; Tysarowski A; Kraszewska E; Siedlecki JA; Walewski J
Med Oncol; 2009; 26(1):16-21. PubMed ID: 18470485
[TBL] [Abstract][Full Text] [Related]
46. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
[TBL] [Abstract][Full Text] [Related]
47. Secondary prophylaxis of an acute coronary syndrome during rituximab infusion.
Triguero Moreno A; Gual Capllonch F; Sancho Cía JM
Med Clin (Barc); 2020 Jan; 154(2):69-70. PubMed ID: 31178296
[No Abstract] [Full Text] [Related]
48. Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia.
Thakral B; Khoury JD
Blood; 2016 Nov; 128(20):2475. PubMed ID: 27856472
[No Abstract] [Full Text] [Related]
49. Successful treatment of histiocytic sarcoma and concurrent HIV infection using a combination of CHOP and antiretroviral therapy.
Narita K; Noro R; Seike M; Matsumoto M; Fujita K; Matsumura J; Takahashi M; Kawamoto M; Gemma A
Intern Med; 2013; 52(24):2805-9. PubMed ID: 24334590
[TBL] [Abstract][Full Text] [Related]
50. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[TBL] [Abstract][Full Text] [Related]
51. A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma.
Bonzheim I; Salaverria I; Haake A; Gastl G; Adam P; Siebert R; Fend F; Quintanilla-Martinez L
Blood; 2011 Sep; 118(12):3442-4. PubMed ID: 21940830
[No Abstract] [Full Text] [Related]
52. Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study.
Hill ME; MacLennan KA; Cunningham DC; Vaughan Hudson B; Burke M; Clarke P; Di Stefano F; Anderson L; Vaughan Hudson G; Mason D; Selby P; Linch DC
Blood; 1996 Aug; 88(3):1046-51. PubMed ID: 8704213
[TBL] [Abstract][Full Text] [Related]
53. Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes.
Raghoebier S; Broos L; Kramer MH; van Krieken JH; Kluin-Nelemans JC; van Ommen GJ; Kluin P
Leukemia; 1995 Oct; 9(10):1748-55. PubMed ID: 7564520
[TBL] [Abstract][Full Text] [Related]
54. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma.
Chan TS; Khong PL; Kwong YL
Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194
[No Abstract] [Full Text] [Related]
55. Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study.
Laurent C; Müller S; Do C; Al-Saati T; Allart S; Larocca LM; Hohaus S; Duchez S; Quillet-Mary A; Laurent G; Brousset P; Valitutti S
Blood; 2011 Nov; 118(20):5371-9. PubMed ID: 21856865
[TBL] [Abstract][Full Text] [Related]
56. Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab refractory patients.
Sieniawski M; Bhartia S; Wilkinson J; Proctor SJ
Leuk Lymphoma; 2009 Oct; 50(10):1726-30. PubMed ID: 19639513
[No Abstract] [Full Text] [Related]
57. 'The sandwich sign' of mesenteric lymphoma.
Hokama A; Nakamoto M; Kinjo F; Fujita J
Eur J Haematol; 2006 Oct; 77(4):363-4. PubMed ID: 16856921
[No Abstract] [Full Text] [Related]
58. [Management of follicular lymphoma].
Izutsu K
Rinsho Ketsueki; 2014 Oct; 55(10):1929-36. PubMed ID: 25297757
[No Abstract] [Full Text] [Related]
59. Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy.
Johnston A; Salles G; Espinouse D; Felman P; André P; Berger F; Coiffier B
Clin Lymphoma Myeloma; 2008 Dec; 8(6):356-8. PubMed ID: 19064401
[TBL] [Abstract][Full Text] [Related]
60. The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Matsumoto C; Hattori Y; Matsuura S; Takasaki H; Hashimoto C; Fujita H; Fujisawa S; Ishigatsubo Y
J Clin Exp Hematop; 2013; 53(2):107-14. PubMed ID: 23995106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
